🔴 Standard Biotools is trading 5% down on October 12, 2026, with no clear catalyst identified

Standard Biotools is trading at $0.65, down 5.03%, with no specific catalyst established for the October 12 decline.

• The latest identified release was an October 5 agreement to sell its Microfluidics business to ARCHIMED; closing is expected in approximately 30 days.
• Broader market indicators were mixed and showed no strong same-direction move to clearly explain the intraday decline.